Investor feedback for Phoenix’s seven year bond in 4% area
Phoenix Pharma is targeting a €250m-€300m bond issue after having finished its investor meetings today. A seven year bond could be sold as early as tomorrow.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
